Cite
HARVARD Citation
Fan, R. et al. (2023). Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma. Journal for immunotherapy of cancer. 11 (1), p. . [Online].